---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-002241"
form_type: "8-K"
ticker: "CBIO"
cik: "0001253689"
company_name: "CRESCENT BIOPHARMA, INC."
filed_at: "2024-03-01T23:59:59+00:00"
generated_at: "2026-06-05T05:18:50.761839+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# GlycoMimetics files 8-K with corporate presentation; no material updates disclosed

## Summary
- Filing includes a slide presentation for anticipated investor meetings, March 2024.
- Presentation focuses on GlycoMimetics' glycobiology-based therapeutic platform.
- No specific financial results, pipeline updates, or guidance changes provided in the filing.
- The presentation contains forward-looking statements and standard disclaimers.
- No new agreements, regulatory decisions, or material events were announced.

## SEC filing metadata
- accession: 0001558370-24-002241
- form_type: 8-K
- ticker: CBIO
- cik: 0001253689
- company_name: CRESCENT BIOPHARMA, INC.
- filed_at: 2024-03-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1253689/000155837024002241/0001558370-24-002241-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1253689/000155837024002241/glyc-20240301x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-002241
- JSON: https://secwatch.observer/filing/0001558370-24-002241.json
- Plain text: https://secwatch.observer/filing/0001558370-24-002241.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.